Roundhill Glp-1 & Weight Loss ETF OZEM

$26.58 +0.08 (0.30%)

Valuation

Market cap
—
Revenue TTM
—
Net income TTM
—
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
14,604
Avg volume
—
Day's range
$26.43 – $26.70
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Latest news

Stocktwits

ripster47 Oct 5, 3:31 PM
$OZEM GLP-1 and Weight Loss Sector been Red for day in row This sector is not going anywhere! Keep eyes
0 replies
Showyouthemoney Sep 29, 10:57 AM
$LLY $NVO $OZEM This article is complete bullshit. Wegovy pill was Much more effective thab Foundayo in trials. Foundayo also has a higher drop out rate.
1 replies
Showyouthemoney Sep 29, 10:55 AM
$LLY $NVO $OZEM
0 replies
StocktwitsNews Sep 29, 10:21 AM
LLY Vs NVO: Foundayo Beats Novo’s Oral Semaglutide On Weight Loss, Blood Sugar In New Finding $LLY $NVO $OZEM https://stocktwits.com/news/equity/markets/lly-vs-nvo-foundayo-oral-semaglutide-weight-loss-blood-sugar-new-finding/cZMmU5cRBgI
0 replies
StocktwitsNews Sep 24, 12:51 PM
VKTX Stock Heads Toward Worst Day In Over A Year Just Days After Promising Weight Loss Drug Data — Here’s What’s Driving The Selloff $VKTX $OZEM https://stocktwits.com/news/equity/markets/vktx-stock-heads-toward-worst-day-in-over-a-year-just-days-after-promising-weight-loss-drug-data-here-s-what-s-driving-the-selloff/cZMJRgPRB9O
0 replies
StocktwitsNews Sep 22, 12:08 PM
VKTX Stock Spikes 38% Premarket: Viking’s VK2735 Shows Promise For Weight-Loss Maintenance $VKTX $OZEM $LLY $NVO https://stocktwits.com/news/equity/markets/why-vktx-stock-soaring-today-weight-loss-maintenance-data/cZMPVzkRBen
0 replies
StocktwitsNews Sep 21, 11:31 AM
Novo Nordisk Targets Over Five New Blockbusters By 2030, But NVO Stock Slides On Growth Concerns $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-targets-over-five-new-blockbusters-by-2030-but-nvo-stock-slides-on-growth-concerns/cZMRWMdRB4u
0 replies
StocktwitsNews Sep 16, 1:05 PM
Novo Nordisk Taps Anthropic’s Claude Science To Speed Up Drug Discovery — Here’s Everything Investors Need To Know $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-taps-anthropic-s-claude-science-to-speed-up-drug-discovery-here-s-everything-investors-need-to-know/cZtY1NqRB2z
0 replies